CABA

0.93617.32%
RC

Richard C. Henriques

Independent Director

Mr. Richard C. Henriques, Jr., also known as Dick, MBA, served as the Chief Financial Officer of Bill & Melinda Gates Foundation from 2010 to 2014. His areas of expertise include corporate controllership and governance, strategic planning, performance measurement and cost management, particularly in the pharmaceutical and pharmacy benefit management industries. Prior to joining the Bill & Melinda Gates Foundation, Mr. Henriques spent 25 years at Merck & Company where he served in key financial positions including Senior Vice President of Finance. He served as Vice President of Finance for Global Human Health of Merck & Co., Inc. from September 1, 2006 to December 2008. He served as Vice President and Controller of Merck & Co., Inc. since August 2002 to September 2006 and also served as its Principal Accounting Officer. He was responsible for the Corporate Controller Group and providing financial support for the Human Health operations in the United States, Canada, Latin America, Europe, the Middle East, Africa, Japan and Australia/New Zealand and the Merck Vaccine Division (MVD). Since November 2000, he served as Vice President and Controller, responsible for the Corporate Controller Group and providing financial support for U.S. Human Health, Canada and Latin America (The Americas) and MVD. Since February 1999, Mr. Henriques also served as the Vice President and Controller of Merck & Co., Inc. and was responsible for providing financial support for The Americas and since January 1998 he served as its Vice President. Since January 1997, he served as Controller of The Americas of Merck & Co., Inc. He served as Finance Advisor of MSD K.K. (formerly, Banyu Pharmaceutical Co. Ltd.) from January 1989 to January 1992 and Manager of MSDI Controller Operations from January 1985 to January 1988 and Manager of Operations Analysis of Asia/LatAm (Pharmaceuticals industry) from January 1982 to January 1985. He was a Financial Analyst of Merck Chemical Manufacturing Division from January 1981 to January 1982. He had been an Independent Non-Executive Director of Arbutus Biopharma Corporation since December 2014 until February 25, 2025. He has been a Director of Pennswood Village, Newtown Friends School and Bowmans Hill Wildflower Preserve since 2009. Mr. Henriques serves as a member of the Board of Directors for The Franklin Institute, the Pennsylvania State Chapter of The Nature Conservancy and Episcopal Community Services (a Philadelphia based social services organization). He is an Independent Director of EMulate Therapeutics, Inc. since 2015. He serves as an Independent Director of MSD K.K., (formerly, Banyu Pharmaceutical Co. Ltd.). He is an Independent Director of Cabaletta Bio, Inc. from February 2019. He has been a Senior Fellow at the University of Pennsylvania with a focus on impact investing since 2015. Mr. Henriques serves as a member of the board of directors for the International Vaccine Institute, The Franklin Institute, Heritage Conservancy, Delaware Canal 21 and Fisherman’s Mark. Mr. Henriques holds BA in Oriental Studies from University of Pennsylvania in 1978 and an MBA with concentration in Finance from The Wharton School in 1981. He is also a Senior Fellow at the Center for High Impact Philanthropy and Wharton Social Impact at the University of Pennsylvania.

Positions